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Sleep Disturbance in Fibromyalgia Syndrome           
 
 
Evaluation of: Bigatti SM, Hernandez AM, Cronan TA, Rand KL: Sleep 
disturbances in fibromyalgia syndrome: relationship to pain and depression. 
Arthritis Rheum. 59(7), 961-967 (2008). Sleep disturbance is a widely reported and 
debilitating concomitant of fibromyalgia syndrome (FMS) and plays a pivotal role in 
exacerbating patients reporting of symptoms. Bigatti and colleagues report a 
longitudinal study that examined self-reported sleep, pain, depression and physical 
functioning at baseline in FMS patients and again at a 12 month follow-up. Their 
results support previous research in showing that there is a bi-directional correlation 
between sleep and pain experience. Moreover the results demonstrated that sleep 
predicted pain, pain predicted physical functioning, and physical functioning 
predicted depression, although causality was not actually demonstrated. Nonetheless, 
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this research highlights the prevalence of sleep problems in FMS, and the critical role 
sleep plays in the quality of life for many patients.  
 
 
Fibromyalgia Syndrome (FMS) is a chronic rheumatic condition characterised by 
widespread pain, tender points and fatigue [1]. Diagnosis is usually confirmed by the 
reporting of persistent and widespread pain for at least three months and pain in 11 
out of 18 tender points on digital palpitation (with the amount of pressure sufficient to 
blanch a finger nail). The exact cause of the condition is not known and symptoms 
can appear at any stage of life, though symptom onset is most typical between the 
ages of 55-64 years [2]. Fibromyalgia Syndrome predominantly affects females 
(female: male ratio of 7-9:1), and it is estimated to affect approximately 4% of the 
adult population [3].  
 Sleep disturbance is a very common complaint and research has demonstrated 
that between 70-90% of FMS patients experience some form of sleep disturbance 
[4,5], although this can be as high as 99% for patients attending self-help groups [6]. 
For some, poor sleep becomes a central issue in the course of FMS and poor sleep is 
inextricably linked with the experience of pain [7,8,9,10]. This association appears to 
be bi-directional with poor sleep linked to increased reporting of pain, and increased 
pain linked to poor sleep [8]. Another common complaint is depression [11,12], 
although less is known about the interaction/s between sleep depression, fatigue, well-
being and physical functioning in FMS. 
 The reviewed paper by Bigatti and colleagues [13] reports a prospective study 
that examined sleep, pain, depression and physical functioning in fibromyalgia 
patients at baseline and at a 12 month follow-up. The study had a reasonable large 
sample of 492 patients with complete data at follow-up. Consistent with previous 
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studies of FMS and sleep, sleep disturbance was highly prevalent with 96% of the 
sample scoring above the threshold. Bigatti et al., however used a cut of score of 5 or 
greater as an indicator of poor sleep, whereas a more stringent global PSQI score of 
>6 has also been considered as being indicative of a sleep disturbance in pain patients 
[14]. 
Notwithstanding, it is clear that sleep is a major health concern in these patients. 
Consistent with previous research [15], it was interesting in the Bigatti et al. study that 
sleep quality remained relatively stable over the 12 months of the study, although 
there was a statistical increase in reported sleep quality at 12 months. However, an 
improvement in the mean global PSQI score of .47 is relatively minor clinically. 
There is currently no effective treatment for sleeping problems in FMS. Medications 
(hypnotics or sedating antidepressants are widely prescribed to improve sleep for 
patients with FMS, although they have been found to have only short term benefits, 
and can have many unwanted side effects [15]. The long term use (over 4-6 weeks) of 
benzodiazepines for the treatment of sleep difficulties is no longer recommended [16].  
 An important, yet unresolved issue in the pain literature is whether sleep 
precedes/predicts pain, or whether pain precedes/predicts sleep quality 
[8,17,18,19,20,21]. The temporal sequence of pain and sleep presents an interesting 
challenge clinically, yet there has only been a small number of studies investigating 
this issue, and the question of directionality remains unanswered. For example, 
Affleck et al., [8] investigated the association between sleep quality and pain intensity 
and attention to pain over 30 consecutive days in 50 women with fibromyalgia 
syndrome. Sleep and pain showed bi-directional correlations, poor sleep was 
associated with a more painful day, and a more painful day was followed by a poor 
nights sleep. The study by Bigatti et al. attempts to add to the literature and examined 
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the relationship between sleep problems and the experience of pain, depression and 
physical functioning. They reported that sleep predicted pain (  = 0.13), pain 
predicted physical functioning (  = -0.13), and physical functioning predicted 
depression (  = -0.10). Bigatti et al’s study differed to the Afflect et al’s study by 
examining the temporal associations over a period of one year, and it is interesting 
that sleep predicted pain 12 months later. What is not clear is why there was a long 
time frame between assessment points, and the authors point out, that future research 
should examine these relationship between these variables repeatedly through-out the 
year. Although the results were based on path analysis, this is essentially a 
correlational procedure and it is therefore difficult to attribute causality. The 
relationship between sleep and pain may be caused by a third variable, such as 
negative affectivity. Nevertheless Bigatti et al’s study highlights the pivotal role sleep 
has in symptom reporting and mood in fibromyalgia syndrome and its potential 
clinical implications.  
Potentially there are many different reasons why patients with FMS experience 
poor sleep. It is been shown that activity levels at night are higher in patients with 
FMS compared to controls [22]. There is also evidence of possible biological factors, 
such as, abnormalities in the sleep physiology of people with FMS. For example, a 
number of studies using polysomnography monitoring have revealed that people with 
FMS have increased stage 1 light sleep [23] and less (Stage 4) slow wave sleep 
[24,25] and are more easily awoken than controls [26]. Further, it has also been 
proposed that people with FMS are more likely to experience an increase in alpha 
waves which are associated with wakefulness, during sleep (known as the alpha-delta 
complex), although the results are inconsistent, and the alpha-delta complex does not 
appear to be specific to people with FMS [27].  
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Medications are often prescribed to ease pain yet many of those commonly used 
to relieve pain in FMS may disturb sleep and can lead to daytime drowsiness thereby 
exacerbating levels of fatigue [28]. The Bigatti et al’s and similar studies, raise an 
interesting possibility that more should be done to treat the underlying sleep disorder, 
and also explore the use of non-pharmacological interventions to improve sleep for 
people with FMS.  
 
Executive summary 
 
Bigatti et al’s study supports existing literature by demonstrating chronic sleep 
problems in patients with fibromyalgia syndrome (FMS) and highlights the pivotal 
role sleep plays in symptom reporting in patients with FMS. 
 
Their results are consistent with previous literature demonstrating a bi-directional 
association between sleep and pain, but the results also demonstrated that sleep 
predicted pain. 
 
Sleep problems are compounded by many medications FMS patients take to deal with 
pain and depression and greater attention should be directed to improving sleep 
quality.  
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